Iressa Shrinks Some Lung Tumors, Reduces Symptoms In Phase II Trial
New Biologic Modalities Show Promise In Treatment Of Lymphomas, Research Finds
Docetaxel As Adjuvant Therapy Shows Benefit Over Standard
QOL Of Anemic Patients Improved With Darbepoetin
UC Davis Study Finds Patients Need Practical Information
Clinical Trials Approved By NCI CTEP During May
Trending Stories
- The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives
In a time of uncertainty, “react to the knowns, not the fear” - How MD Anderson and Texas Children’s made plans to build a $1 billion pediatric cancer hospital—one of the world’s largest
- In the Headlines: MD Anderson’s Pisters on doing “something gigantic for pediatric cancer”
- As cancer scientists, we must change how we engage with the public on the impact of NIH cuts
What the scientific method obscures - In weekly vigils, current and former NIH staff grieve the impact of Trump cuts
The Saturday gatherings at NIH’s Metro station are part graveside service, part street theater - Scaling excellence: How City of Hope is transforming cancer care delivery